Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Goldberg

Showing results (241-250 of 270) with videos related to

Pageof 27
Sort By:
Journal of Pain and Symptom Management|May 28, 2026
Social Determinants of Health And End-Of-Life Circumstances in A Quaternary Children's HospitalTara Jamieson, Jessica P Liu, Sarah W Goldberg, et al.
Iscience|September 20, 2021
STING nuclear partners contribute to innate immune signaling responsesCharles R Dixon, Poonam Malik, Jose I de Las Heras, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Cells|February 6, 2019
Host Vesicle Fusion Protein VAPB Contributes to the Nuclear Egress Stage of Herpes Simplex Virus Type-1 (HSV-1) ReplicationNatalia Saiz-Ros, Rafal Czapiewski, Ilaria Epifano, et al.
Journal of Rehabilitation Research and Development|December 14, 2007
Effects of co-occurring disorders on employment outcomes in a multisite randomized study of supported employment for people with severe mental illnessJudith A Cook, Lisa A Razzano, Jane K Burke-Miller, et al.
Journal of Medicinal Chemistry|December 19, 2019
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)amino]-9-(tetrahydro-2<i>H</i>-pyran-4-yl)-7,9-dihydro-8<i>H</i>-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) InhibitorFrederick W Goldberg, M Raymond V Finlay, Attilla K T Ting, et al.
Community Mental Health Journal|January 13, 2006
Demographic characteristics and employment among people with severe mental illness in a multisite studyJane K Burke-Miller, Judith A Cook, Dennis D Grey, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8<i>H</i>-purin-8-one Inhibitors of DNA-PKFrederick W Goldberg, Attilla K T Ting, David Beattie, et al.
Nature Communications|January 17, 2017
Repo-Man/PP1 regulates heterochromatin formation in interphaseInês J de Castro, James Budzak, Maria L Di Giacinto, et al.
The Journal of Nervous and Mental Disease|November 2, 2005
Clinical factors associated with employment among people with severe mental illness: findings from the employment intervention demonstration programLisa A Razzano, Judith A Cook, Jane K Burke-Miller, et al.
Pageof 27

Showing results (241-250 of 270) with videos related to

Sort By:
Pageof 27
Journal of Pain and Symptom Management|May 28, 2026
Social Determinants of Health And End-Of-Life Circumstances in A Quaternary Children's HospitalTara Jamieson, Jessica P Liu, Sarah W Goldberg, et al.
Iscience|September 20, 2021
STING nuclear partners contribute to innate immune signaling responsesCharles R Dixon, Poonam Malik, Jose I de Las Heras, et al.
Journal of Medicinal Chemistry|December 16, 2022
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for OncologyFrederick W Goldberg, Jason G Kettle, Gillian M Lamont, et al.
Cells|February 6, 2019
Host Vesicle Fusion Protein VAPB Contributes to the Nuclear Egress Stage of Herpes Simplex Virus Type-1 (HSV-1) ReplicationNatalia Saiz-Ros, Rafal Czapiewski, Ilaria Epifano, et al.
Journal of Rehabilitation Research and Development|December 14, 2007
Effects of co-occurring disorders on employment outcomes in a multisite randomized study of supported employment for people with severe mental illnessJudith A Cook, Lisa A Razzano, Jane K Burke-Miller, et al.
Journal of Medicinal Chemistry|December 19, 2019
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)amino]-9-(tetrahydro-2<i>H</i>-pyran-4-yl)-7,9-dihydro-8<i>H</i>-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) InhibitorFrederick W Goldberg, M Raymond V Finlay, Attilla K T Ting, et al.
Community Mental Health Journal|January 13, 2006
Demographic characteristics and employment among people with severe mental illness in a multisite studyJane K Burke-Miller, Judith A Cook, Dennis D Grey, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8<i>H</i>-purin-8-one Inhibitors of DNA-PKFrederick W Goldberg, Attilla K T Ting, David Beattie, et al.
Nature Communications|January 17, 2017
Repo-Man/PP1 regulates heterochromatin formation in interphaseInês J de Castro, James Budzak, Maria L Di Giacinto, et al.
The Journal of Nervous and Mental Disease|November 2, 2005
Clinical factors associated with employment among people with severe mental illness: findings from the employment intervention demonstration programLisa A Razzano, Judith A Cook, Jane K Burke-Miller, et al.
Pageof 27